HOME >> BIOLOGY >> NEWS
Parkinson's protein protects neurons from stress induced cell death

The scientists could show that Parkin prevents the induction of neuronal cell death. As reported in the "Journal of Neuroscience", the protein activates a survival mechanism which had been known for its prominent role in immune response.

Usually, Parkinsons disease occurs after the age of 50 and in Germany about 400,000 people are affected. It is characterized by a decline of neurons in the so-called Substantia Nigra, a structure in the midbrain that produces dopamine. The resulting deprivation of this messenger substance causes symptoms like muscular tremor at rest and restricted mobility and even complete immobility. Characteristic deposits are found in the brain, the Lewy corpuscles.

Little is known about the causes of Parkinsons disease. It has only been known for a few years that ten to fifteen per cent of all cases are associated with mutations in certain genes.

"The parkin gene is of special interest here", says Winklhofer. "One effect of its inactivation is that the Parkin protein loses its physiological function. This genetic defect plays a role for hereditary Parkinsons disease, which may lead to an early onset of the disease."

However, inactivation of the Parkin protein could also contribute to sporadic forms of the disease. In these cases massive oxidative stress probably results in misfolding and aggregation of the protein. "Interestingly, misfolding of Parkin proteins has recently been observed in the brain of patients with sporadic Parkinsons disease", Winklhofer reports.

The scientists could now show in their study that Parkin protects the neuronal cells by mediating the activation of the nuclear protein NF-B ("Nuclear Factor-kappaB"). This protein is known for triggering a survival programme in many human cells, which prevents cell death under stress conditions. The experiments indicate that mutations in the parkin gene result in an impaired activation of NF-B.

"This, however, promo
'"/>

Contact: Heinz-Joerg Haury
oea@gsf.de
49-893-187-2460
GSF - National Research Center for Environment and Health
21-May-2007


Page: 1 2

Related biology news :

1. Scientists identify 2 distinct Parkinsons networks
2. Tracing Parkinsons lethal mechanism
3. Lancet study shows gene therapy for Parkinsons disease is safe and some patients benefit
4. Gene therapy study shows safety and statistically significant improvement in Parkinsons disease
5. PINK1 protects from Parkinsons
6. UCLA researchers discover link between Parkinsons and narcolepsy
7. Alzheimers, Parkinsons, type 2 diabetes similar at molecular level
8. Nanotechnology offers hope for treating spinal cord injuries, diabetes and Parkinsons disease
9. New studies link the environment to Parkinsons disease
10. NIH announces phase III clinical trial of creatine for Parkinsons disease
11. The Parkinsons Institute to conduct Phase III Clinical Trial of creatine for Parkinsons disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/30/2019)... Md. (PRWEB) , ... September ... ... biotechnology market disrupter and leading supplier of innovative human mesenchymal stem/stromal cell ... for novel product formulations related to “Ready-to-Print” (RTP) cellular product formats (patent ...
(Date:9/25/2019)... ... September 25, 2019 , ... LeadingBiotech , an ... today announces its inaugural South CEO conference to be held on ... Co-produced by Tulane University, this invitation-only meeting convenes biopharma executives to discuss pressing ...
(Date:9/24/2019)... (PRWEB) , ... September 24, 2019 , ... ... companies characterize protein interactions for accelerated drug development, announced today that it has ... was led by OS Fund and also includes AME Cloud Ventures, Boom Capital, ...
Breaking Biology News(10 mins):
(Date:10/17/2019)... OVERLAND PARK, Kan. (PRWEB) , ... October 15, ... ... rating to 23andMe, a leader among services that offer DNA Testing for health ... become so popular. Everywhere you look, it seems that people want to know ...
(Date:10/10/2019)... ... October 09, 2019 , ... The ... Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for the 2019 ... Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative medicine physician, is ...
(Date:10/10/2019)... ... October 10, 2019 , ... VirTrial ... research centers in Europe. All Pratia research centers have completed VirTrial’s Virtual Trial ... and certified as Virtual Trial Capable and prepared to conduct decentralized clinical trials ...
(Date:10/8/2019)... BOSTON (PRWEB) , ... October 08, 2019 , ... Today, ... U.K. of its lead development technology. Like the company’s precursor patent, approved in ... and accurate counting of tissue stem cells. Asymmetrex now markets the technology in ...
Breaking Biology Technology:
Cached News: